MBX-2982 - CAS# 1037792-44-1 size:2mg solid Formulation is 10% N-methylpyrrilidone

Formulation is 10% N-methylpyrrilidone

most selective 5- HT2B receptor ligands

Rodvold KA

MDV-3100 also prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex

) produces robust phase delays

MBX-2982 - CAS# 1037792-44-1 size:2mg solid Formulation is 10% N-methylpyrrilidoneMBX 2982, also known as SAR 260093, CAS No. 1037792 44 1, is a potential first in class treatment for type 2 diabetes that targets G protein coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose dependent insulin secretion. Preclinical data indicate that MBX 2982 is a potent selective orally active GPR119 agonist that functions through a unique dual mechanism of action. First, it acts directly on the